bladder cancer
Showing NaN - NaN of 57
Bladder Cancer Trial in Australia, New Zealand, United Kingdom (WBRT, SART, DART)
Active, not recruiting
- Bladder Cancer
- WBRT
- +2 more
-
Wagga Wagga, New South Wales, Australia
- +48 more
Jun 5, 2020
Urinary Bladder Cancer, Bladder Cancer, Bladder Tumors Trial in Canada, United States (Vicinium)
Completed
- Urinary Bladder Cancer
- +3 more
-
Tallahassee, Florida
- +20 more
Apr 30, 2020
Bladder Cancer Trial in Canada (biological, drug, procedure)
Terminated
- Bladder Cancer
- BCG vaccine
- +2 more
-
Vancouver, British Columbia, Canada
- +5 more
Apr 1, 2020
Bladder Cancer Trial in United Kingdom (Mitomycin C, Surgical Management)
Unknown status
- Bladder Cancer
- Mitomycin C
- Surgical Management
-
Macclesfield, Cheshire, United Kingdom
- +37 more
Mar 17, 2020
To Detect the Sensitivity of the UroMark Assay
Unknown status
- Bladder Cancer
-
Ashton-under-Lyne, United Kingdom
- +18 more
Oct 8, 2019
The Cxbladder Rule-out of Recurrent Urothelial Carcinoma
Unknown status
- Bladder Cancer
- Cx bladder Monitor test
-
London, Ontario, CanadaVictoria Hospital
Aug 12, 2019
Bladder Cancer Trial in Worldwide (Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody, Docetaxel,
Completed
- Bladder Cancer
- Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody
- +3 more
-
Washington, District of Columbia
- +216 more
Jul 5, 2019
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,
Completed
- Bladder Cancer
- +3 more
- carboplatin
- +3 more
-
Glasgow, Scotland, United Kingdom
- +20 more
May 14, 2019
Bladder Cancer Trial in London, Middlesbrough (Group)
Completed
- Bladder Cancer
- Group
-
London, United Kingdom
- +1 more
Apr 16, 2019
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United Kingdom (cisplatin,
Completed
- Bladder Cancer
- +2 more
- cisplatin
- +2 more
-
Bristol, Avon, United Kingdom
- +15 more
Oct 25, 2018
NMP22 Provides Improved Sensitivity in Detecting Bladder
Completed
- Bladder Cancer
- Nuclear Matrix Protein 22 Urine sample kit
-
London, Ontario, CanadaLondon Health Sciences Centre
Aug 24, 2017
Anal Cancer, Bladder Cancer, Cervical Cancer Trial in London (dietary supplement, other, procedure, radiation)
Completed
- Anal Cancer
- +8 more
- dietary intervention
- +4 more
-
London, England, United KingdomRoyal Marsden - London
Oct 31, 2016
Bladder Cancer Trial in United Kingdom (Standard planning radiotherapy, Adaptive planning radiotherapy)
Active, not recruiting
- Bladder Cancer
- Standard planning radiotherapy
- Adaptive planning radiotherapy
-
Cambridge, United Kingdom
- +10 more
Aug 9, 2016
Bladder Cancer Trial in London (Metformin, Simvastatin)
Unknown status
- Bladder Cancer
-
London, Ontario, CanadaLondon Health Sciences Center; Victoria Hospital
Jul 7, 2016
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (bortezomib)
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
-
Chicago, Illinois
- +14 more
Jul 22, 2015
Bladder Cancer Trial in United Kingdom (lapatinib ditosylate, Placebo)
Unknown status
- Bladder Cancer
- lapatinib ditosylate
- Placebo
-
London, England, United Kingdom
- +26 more
Apr 14, 2015
Bladder Cancer Trial in London (biological, drug, radiation)
Completed
- Bladder Cancer
- BCG vaccine
- +2 more
-
London, England, United KingdomMiddlesex Hospital- Meyerstein Institute
Dec 17, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Worldwide (fluorouracil)
Completed
- Bladder Cancer
- +2 more
-
Porto Alegre, Rio Grande do Sul, Brazil
- +61 more
Dec 3, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (oxaliplatin)
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
-
Chicago, Illinois
- +13 more
Sep 4, 2013